LOCUS       sequence-65075-e         998 bp    DNA     linear   UNA 15-DEC-2025
DEFINITION  natural linear DNA
ACCESSION   .
VERSION     .
KEYWORDS    .
SOURCE      natural DNA sequence
  ORGANISM  unspecified
REFERENCE   1  (bases 1 to 998)
  AUTHORS   Brower CS, Shilatifard A, Mather T, Kamura T, Takagi Y, Haque D, 
            Treharne A, Foundling SI, Conaway JW, Conaway RC
  TITLE     The elongin B ubiquitin homology domain. Identification of Elongin B
            sequences important for interaction with Elongin C.
  JOURNAL   J Biol Chem. 1999 May 7;274(19):13629-36.
  PUBMED    10224134
REFERENCE   2  (bases 1 to 998)
  AUTHORS   .
  TITLE     Direct Submission
  JOURNAL   Exported Dec 15, 2025 from SnapGene Server 8.0.1
            https://www.snapgene.com
COMMENT     SGRef: number: 1; type: "Journal Article"; journalName: "J Biol 
            Chem."; date: "1999-05-7"; volume: "274(19)"; pages: "13629-36"
COMMENT     Sequence Label: pCIneo-EloC
FEATURES             Location/Qualifiers
     source          1..998
                     /mol_type="genomic DNA"
                     /organism="unspecified"
     promoter        complement(411..429)
                     /label=T7 promoter
                     /note="promoter for bacteriophage T7 RNA polymerase"
     primer_bind     complement(472..491)
                     /label=pMT2-F
                     /note="Synthetic intron, forward primer"
     intron          474..606
                     /label=chimeric intron
                     /note="chimera between introns from human beta-globin and 
                     immunoglobulin heavy chain genes"
     primer_bind     complement(746..770)
                     /label=LNCX
                     /note="Human CMV promoter, forward primer"
     promoter        complement(767..977)
                     /label=CMV promoter
                     /note="human cytomegalovirus (CMV) immediate early 
                     promoter"
     primer_bind     complement(796..816)
                     /label=CMV-F
                     /note="Human CMV immediate early promoter, forward primer"
ORIGIN
        1 cgaagcatta accctcacta aagggaagcg gccgcccggg tcgagaattc aacaatctag
       61 gaagtttgca gccatcagca gttccagtgc aatttcaggt gcaattggga attcaggaat
      121 ctcggtggag ctgttagtgt agcgaacctt gtacgtaaaa tacatgcata ctttcgatag
      181 cacatgtgaa ggtatctctc taaaattgac ctcattggtt tcgttctcag caaactgacc
      241 tgggccactc aacatggctt ttatcgtgcc tgatgttaat gcatgttctc tttttacaat
      301 aaattcatgg ccatcagatg atatcaattt gacatacatg gcatcaggtc cttcacagcc
      361 accataggtt ttctcctctc catccatgct agattcgaac tcgaggctag cctatagtga
      421 gtcgtattaa gtactctagc cttaagagct gtaattgaac tgggagtgga cacctgtgga
      481 gagaaaggca aagtggatgt cagtaagacc aataggtgcc tatcagaaac gcaagagtct
      541 tctctgtctc gacaagccca gtttctattg gtctccttaa acctgtcttg taaccttgat
      601 acttacctgc ccagtgcctc acgaccaact tctgcaaggc taccttaaga gagtcactgc
      661 agcttaagtt cgagactgtt gtgtcagaag cactgactgc gttagcaatt taactgtgat
      721 aaactaccgc aataaagctt ctagtgatct gacggttcac taaacgagct ctgcttatat
      781 agacctccca ccgtacacgc ctaccgccca tttgcgtcaa cggggcgggc gatcgcagtt
      841 gttacgacat tttggaaagt cccgttgatt ttggtgccaa acaaactccc attgacgtca
      901 atggggtgga gacttggaaa tccccgtgag tcaaaccgct atccacgccc attggtgtac
      961 tgccaaaacc gcatcaccat ggtaatagcg atgactaa
//
